A construction worker pops a leftover painkiller before climbing scaffolding because his back never fully healed. A long-haul trucker drinks alone in a motel room after a 14-hour shift. A warehouse employee takes a pill she bought from a coworker just to get through the night rotation. None of them show up in a headline until something goes wrong on the clock.
Something is going wrong with alarming frequency. The Bureau of Labor Statistics’ Census of Fatal Occupational Injuries recorded 525 unintentional overdose deaths in American workplaces in 2022, the most recent year with finalized data. That figure has more than doubled since 2013, when the count stood at 165. The trajectory has been steep and consistent: in 2018 the toll was 305; by 2020 it had climbed to 388. Each number represents a person who died on the job from a drug that was not taken as prescribed, or was never prescribed at all.
Behind the body count is a pattern that federal occupational health scientists have documented across multiple surveillance systems. Chronic job stress, physical pain from workplace injuries, and grinding burnout are pushing employees toward alcohol and drugs as a coping mechanism. The National Institute for Occupational Safety and Health has stated the connection plainly: work-related injury and working conditions can increase risks for harmful substance use.
The jobs where risk runs highest
Not every worker faces the same exposure. NIOSH and BLS data consistently flag construction, mining, transportation, and food service as sectors with elevated overdose rates. Construction stands out. Workers in the trades suffer musculoskeletal injuries at high rates, are frequently prescribed opioids for acute pain, and often lack stable employer-sponsored health coverage that would support longer-term treatment. A NIOSH bulletin on mental health and substance use ties this injury-to-opioid pipeline directly to prescribing patterns and inadequate follow-up care.
Transportation and warehousing present a different but overlapping risk profile. Long hours, irregular schedules, isolation, and sleep deprivation create conditions where stimulants or sedatives become functional tools rather than recreational choices. The 2022 National Survey on Drug Use and Health, published by the Substance Abuse and Mental Health Services Administration, found that roughly 48.7 million Americans aged 12 and older had a substance use disorder in the prior year. The survey does not break that figure down by occupation with enough precision to rank specific jobs, but it confirms that the reservoir of at-risk workers is enormous.
How stress becomes substance use
Saying “stressed workers drink more” is true but incomplete. Researchers have tested more specific explanations. A peer-reviewed study published in the Journal of Occupational Health Psychology (PMID 28090129) examined what its authors call a biphasic self-medication model. The idea is that the cycle has two distinct phases: a worker initially reaches for alcohol seeking its short-term stimulant effect, a quick mood lift after a punishing shift. As the evening continues, the same person keeps drinking for the sedative effect, trying to quiet anxiety and fall asleep. Over time, this two-phase pattern deepens dependence in ways that simple volume of consumption does not capture.
The model was tested using moderated mediation analysis and offers a mechanistic explanation for why job stress does not just increase how much people drink but changes how they drink. That distinction matters for prevention: interventions aimed only at reducing quantity miss the underlying behavioral loop.
A separate peer-reviewed study, also indexed on PubMed, found that the relationship between work stressors and employee substance use depends heavily on when and how researchers measure it. Surveys administered immediately after a shift yield different results than those given days later. The finding complicates neat cause-and-effect claims but does not weaken the overall association. If anything, it suggests that snapshot surveys undercount the problem.
What the numbers miss
The official death toll, as stark as it is, almost certainly understates reality. The BLS counts a workplace overdose only when the fatal event occurs on the job or is clearly tied to work duties. It does not capture the far larger number of workers who die at home or in emergency rooms after years of job-related pain, stress, or exposure to addictive medications. Nonfatal overdoses, near-misses, and the slow erosion of daily functioning that precedes a crisis go uncounted entirely.
The surge of illicitly manufactured fentanyl into the drug supply since 2019 has made every instance of nonmedical drug use more dangerous, including use that happens at or around work. A worker who five years ago might have taken a counterfeit pill and felt sick now faces a meaningful chance of respiratory arrest. That pharmacological shift helps explain why workplace overdose deaths jumped so sharply between 2018 and 2022 even as overall workplace injury rates held relatively steady.
Stigma is another blind spot. NIOSH identifies it as a modifiable workplace factor linked to mental health problems and substance use, and the agency offers prevention resources aimed at employers and workers alike. But no large federal surveillance system captures why an individual worker chose substances over treatment, or whether that person felt unable to ask for help without risking termination. That qualitative dimension is largely absent from the official record.
What employers and policymakers are weighing
Some companies have begun responding. Employee assistance programs, once a checkbox benefit buried in onboarding paperwork, are being redesigned at firms in construction and logistics to offer same-day counseling and confidential substance use referrals. A smaller number of employers in high-risk sectors have started stocking naloxone on job sites, treating overdose reversal the way they treat first aid for falls or burns. Peer support programs, modeled on approaches used in fire departments and the military, are gaining traction in the building trades.
Whether these interventions actually reduce overdose rates remains an open question. Few large-scale studies have measured the impact of specific workplace policies, such as nonpunitive return-to-work agreements or on-site medication-assisted treatment, on substance use outcomes over time. NIOSH has called for tighter integration of mental health, substance use, and injury data across federal systems, arguing that current databases silo these issues in ways that obscure the connections between them.
Researchers say the next priority is expanding the evidence base beyond alcohol. The biphasic self-medication framework offers a useful template, but opioids, stimulants, and sedatives have different pharmacological profiles and social contexts. Longitudinal studies that follow injured workers over months and years, rather than surveying them at a single point, would help clarify how a back injury on a Tuesday becomes a dependency by December.
A crisis rooted in the workday
None of the existing research proves that any single job causes addiction. What it does show, through converging lines of federal data and peer-reviewed analysis, is that the conditions under which millions of Americans earn a living can make harmful substance use substantially more likely. Demanding schedules, dangerous tasks, inadequate pain management, and cultures that punish vulnerability form a pipeline that feeds the broader overdose crisis.
As of May 2026, the most defensible reading of the evidence is that workplace stress and injury are not peripheral factors in that crisis. They are structural ones. And any serious prevention strategy has to engage the place where most adults spend the largest share of their waking hours: the job.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
